BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Revenue
BRAIN Biotech AG
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Revenue
€55.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Revenue
€6.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Evonik Industries AG
XETRA:EVK
|
Revenue
€15.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
Covestro AG
XETRA:1COV
|
Revenue
€14.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Revenue
€540.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Revenue
€4.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
See Also
What is BRAIN Biotech AG's Revenue?
Revenue
55.2m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Revenue amounts to 55.2m EUR.
What is BRAIN Biotech AG's Revenue growth rate?
Revenue CAGR 5Y
6%
Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for BRAIN Biotech AG have been 14% over the past three years , 6% over the past five years .